-
Sequencing of Liposomal Daunorubicin/Cytarabine Versus Hypomethylating Agents Plus Venetoclax for Secondary Acute Myeloid Leukemia
18 Jun 2025 17:43 GMT
… Agents Plus Venetoclax for Secondary Acute Myeloid Leukemia" at the 2025 … sequencing in patients with secondary acute myeloid leukemia (sAML) who received both … specific care.
Abstract
Background
Secondary acute myeloid leukemia (sAML) is a subtype of …
-
Joshua Zeidner Co-Authored a Study on a Promising Novel Drug for Acute Myeloid Leukemia
18 Jun 2025 17:42 GMT
… a promising treatment approach for acute myeloid leukemia (AML). The early-phase clinical …
-
Senti Bio Granted U.S. FDA Orphan Drug Designation for Use of First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, SENTI-202 to Treat Acute Myeloid Leukemia
18 Jun 2025 11:00 GMT
… -202 for the treatment of Acute Myeloid Leukemia (AML) 20,800 newly diagnosed …
-
CERo Therapeutics Holdings, Inc. Announces FDA Orphan Drug Designation Granted to CER-1236 for the Treatment of Acute Myeloid Leukemia (AML)
17 Jun 2025 12:15 GMT
… -1236, for the treatment of acute myeloid leukemia (AML). CER-1236 is an … CER-1236 in patients with acute myeloid leukemia that is either relapsed…
-
Debiopharm’s ADC Research Gains Momentum With Launch of First-in-human Trial Assessing Debio 1562M in Acute Myeloid Leukemia Patients
16 Jun 2025 12:25 GMT
… /refractory (R/R) acute myeloid leukemia (AML). This phase 1… ADC for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS … . 2020. SEER Cancer Stat Facts: Acute Myeloid Leukemia. Available at: https:/…
-
New drug combination shows high remission rates in acute myeloid leukemia
13 Jun 2025 17:15 GMT
… of care for newly diagnosed acute myeloid leukemia (AML) showed high rates of …
-
EHA 2025: Top 5 Takeaways for Hematologic Malignancy Management
19 Jun 2025 01:44 GMT
… older patients with newly diagnosed acute myeloid leukemia (AML) harboring NPM1 mutations or … newly diagnosed older adults with acute myeloid leukemia (AML) and NPM1 mutation or …
-
Midyear Roundup: FDA’s Novel Oncology Drug Approvals in 2025
19 Jun 2025 00:47 GMT
… -small cell lung cancer (NSCLC), acute myeloid leukemia, and ovarian cancer.
Datopotamab deruxtecan … 1 year and older with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS …
-
UNC School of Medicine faculty featured across multiple media outlets
19 Jun 2025 00:39 GMT
… on a drug combination for acute myeloid leukemia (AML) patients with specific genetic …
-
Aptevo Therapeutics Skyrockets on Game-Changing AML Drug News
18 Jun 2025 23:10 GMT
… the park for patients with acute myeloid leukemia (AML). Let’s break this …